Cosmo Pharmaceuticals NV
SIX:COPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
IE |
|
A
|
AT Semicon Co Ltd
KOSDAQ:089530
|
KR |
|
S
|
Sitio Royalties Corp
NYSE:STR
|
US |
|
Z
|
Zhejiang Yankon Group Co Ltd
SSE:600261
|
CN |
|
B
|
Bhiraj Office Leasehold Real Estate Investment Trust
SET:BOFFICE
|
TH |
|
B
|
Byggma ASA
OSE:BMA
|
NO |
|
T
|
TechNVision Ventures Ltd
BSE:501421
|
IN |
Wall Street
Price Targets
COPN Price Targets Summary
Cosmo Pharmaceuticals NV
According to Wall Street analysts, the average 1-year price target for
COPN
is 126.68 CHF
with a low forecast of 102.01 CHF and a high forecast of 147 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is COPN's stock price target?
Price Target
126.68
CHF
According to Wall Street analysts, the average 1-year price target for
COPN
is 126.68 CHF
with a low forecast of 102.01 CHF and a high forecast of 147 CHF.
What is Cosmo Pharmaceuticals NV's Revenue forecast?
Projected CAGR
26%
For the last 14 years the
compound annual growth rate for
Cosmo Pharmaceuticals NV's revenue is
8%.
The projected
CAGR
for the next 3 years is
26%.
